Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 

17 Percent of HIV/AIDS Cases Due to Injection Drug Use
April 11, 2008

Email
Email
Print
Print
SubscribeSubscribe
Research Summary

A report from the Centers for Disease Control and Prevention (CDC) found that 17 percent of all new adolescent and adult HIV/AIDS cases reported in 2006 were caused by injection-drug use, the Center for Substance Abuse Research at the University of Maryland at College Park reported April 7.

The CDC said that 13 percent of the cases were solely linked to injection-drug use, while 4 percent were caused by injection-drug use in combination with male-to-male sexual contact.

Overall, male-to-male sexual contact was blamed for 50 percent of all new HIV/AIDS cases in 2006, while 33 percent of cases were linked to high-risk heterosexual contact. The study was limited to HIV/AIDS among individuals ages 13 and older in the U.S.

The findings were published in the CDC's annual HIV/AIDS Surveillance Report.

This article summarizes an external report or press release on research published in a scientific journal. When available, links to the sources are provided above.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (guidelines):

Name:

Comment:
(limit 200
words)

Enter this word
(help):
Change

GUIDELINES:
Comments are meant for thoughtful public discussion of the article published above. Therefore:

  1. Keep it clean, courteous, focused, and on-topic.

  2. Do not post personal requests for help (see resources).

  3. Proof your comments carefully for spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

  4. Deceptive, slanderous and commercially-motivated comments are prohibited.

We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.